Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma
- 150 Downloads
Ovarian cancer is influenced by exogenous and endogenous estrogens as suggested by experimental and epidemiological evidence. Estrogen receptor beta is a predominant estrogen receptor in the normal ovary. Polymorphisms in the estrogen receptor beta gene (ESR2) might influence epithelial ovarian risk through regulation of cell proliferation and apoptosis. This population-based case–control study included 313 women with epithelial ovarian carcinoma and 574 controls, frequency-matched on age and ethnicity. Unconditional logistic regression was used to test associations of rs1271572, rs1256030, rs1256031, and rs3020450 ESR2 genotypes with ovarian cancer risk. Compared to homozygous common allele carriers, homozygous carriers of variant alleles for rs1271572 [odds ratio (OR) = 1.79, 95% confidence interval (CI):1.15–2.79, p global = 0.01] and rs1256030 [OR = 1.67, CI: 1.08–2.59, p global = 0.04], and women with haplotypes, including variant alleles of rs1271572, rs1256030, and rs1256031 SNPs [OR = 1.75, CI: 1.17–2.63, p global = 0.007], had significantly increased risk of ovarian carcinoma. The association of the rs1271572 genotype was strongest among women who had never used contraceptive steroids (p for interaction = 0.04). Our data suggest that ESR2 might be a susceptibility marker for epithelial ovarian cancer.
KeywordsEpithelial ovarian cancer ESR2 Single nucleotide polymorphisms Case–control study
This study was supported in part by Public Health Service grant R01-CA-58598 and by contracts N01-CN-67001 and NO1-CN-25403 from the Department of Health and Human Services, National Institutes of Health.
- 1.Parkin DM, Whelan SL, Ferlay J, Teppo L (2002) Cancer incidence in five continents. IARC, Lyon, FranceGoogle Scholar
- 10.Brandenberger AW, Tee MK, Jaffe RB (1998) Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues. J Clin Endocrinol Metab 83:1025–1028. doi: 10.1210/jc.83.3.1025 PubMedCrossRefGoogle Scholar
- 22.Anonymous (1986) Surveillance, epidemiology, and end results program. Summary staging guide for the cancer surveillance, epidemiology, and end results reporting (SEER) Program. U.S. Department of Health and Human Services, Public Health Services, National Institute of Health, Bethesda, MDGoogle Scholar
- 23.Oyama N, Johnson DB (1986) Hawaii health surveillance program survey methods and procedures. R & S Report No 54. State Department of Health Research and Statistics Office, Honolulu, HawaiiGoogle Scholar
- 26.Chen YC, Kraft P, Bretsky P et al (2007) Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 16:1973–1981. doi: 10.1158/1055-9965.EPI-07-0431 PubMedCrossRefGoogle Scholar